Episode
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
- Podcast
- Hematologic Oncology Update
- Published
- Jun 28, 2026
- Duration seconds
- 3103
- Processing state
not_requested- Canonical source
- https://hematologic-oncology.captivate.fm/episode/6009-gmo26-aml
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/acute-myeloid-leukemia-fifth-annual-national-general-medical-oncology-summit/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/acute-myeloid-leukemia-fifth-annual-national-general-medical-oncology-summit.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Courtney D DiNardo and Dr Harry Paul Erba, including the following topics: Introduction (0:00) Current Management Approaches for FLT3- and IDH-Mutated Acute Myeloid Leukemia (AML) — Dr DiNardo (9:44) Current and Future Role of Menin Inhibitors for Patients with AML — Dr Erba (32:07) CME information and select publications